Biosig Technologies Inc (NASDAQ:BSGM) shares traded 24.07% higher at $2.01 on Wall Street last session.
BSGM stock price is now 160.14% away from the 50-day moving average and -55.40% away from the 200-day moving average. The market capitalization of the company currently stands at $18.75M.
With the price target of $9, ROTH Capital recently initiated with Buy rating for Biosig Technologies Inc (NASDAQ: BSGM).
In other news, LONDONER KENNETH L, Chief Executive Officer bought 15,600 shares of the company’s stock on Jun 13 ’23. The stock was bought for $19,358 at an average price of $1.24. Upon completion of the transaction, the Chief Executive Officer now directly owns 2,507,020 shares in the company, valued at $5.04 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 12 ’23, Chief Executive Officer LONDONER KENNETH L bought 6,000 shares of the business’s stock. A total of $7,040 was incurred on buying the stock at an average price of $1.17. This leaves the insider owning 2,491,420 shares of the company worth $5.01 million. A total of 17.06% of the company’s stock is owned by insiders.
During the past 12 months, Biosig Technologies Inc has had a low of $0.26 and a high of $16.50. The fifty day moving average price for BSGM is $0.7726 and a two-hundred day moving average price translates $4.5063 for the stock.
The latest earnings results from Biosig Technologies Inc (NASDAQ: BSGM) was released for Sep, 2023. According to the Medical Devices Company, earnings per share came in at -$0.6, beating analysts’ expectations of -$1 by 0.4. This compares to -$1.44 EPS in the same period last year. The net profit margin was -21307.80% and return on equity was -6869.27% for BSGM. The company reported revenue of $1000.0 for the quarter, compared to $0.14 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -99.26 percent. For the current quarter, analysts expect BSGM to generate $100k in revenue.
